Status:
UNKNOWN
Isthmocele Development Due to Primary Cesarean Section at The Latent or Active Phase
Lead Sponsor:
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Conditions:
Uterus; Scar
Eligibility:
FEMALE
18-45 years
Brief Summary
The importance of isthmocele development due to primary cesarean section at the latent or active phase of labour
Detailed Description
The dates between February 2021 to December 2021 , primiparous (primigravida) and multiparous (multigravida) patients who were hospitalized for delivery between 32 and 41 weeks of gestation and who ha...
Eligibility Criteria
Inclusion
- Pregnant women with the gestational weeks between 32-41 primigravida or multigravida with no history of caesarean section
Exclusion
- Gestational age below 32 weeks
- Confirmed Plasenta Previa and/or placental invasion anomalies
- A history Caeserean Section
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 2 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04891042
Start Date
February 1 2021
End Date
December 2 2021
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zeynep Kamil Maternity and Childrens Training and Research Hospital
Istanbul, Uskudar, Turkey (Türkiye), 34668